,31 Here, we assessed whether silencing Stat3 with CpG-Stat3 siRNA can significantly enhance the efficacies of CTLA4 antibody therapy in B cell lymphoma by augmenting the immunostimulatory effects. This evidence concerns the gene CTLA4 and B-cell non-Hodgkin lymphoma.